|ECR 2019 / C-0185||
|Neurooncology pending battles: is it possible to differentiate true progression from pseudoprogression?|
Accurate differentiation between pseudoprogression and true progression remains challenging for optimal treatment.
Diffusion and perfusion MRI may demonstrate different diagnostic values for predicting pseudoprogression in treated gliomas.
Thematically related posters
ECR 2019 / C-2567
Using ASL-perfusion to detection of residual glioblastoma tissue after surgical treatment
ECR 2019 / C-0958
Differentiation of biopsy-proven true and pseudo-progression by conventional and functional MRI sequences